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INTRODUCTION Benign paroxysmal positional
vertigo (BPPV) is a clinical syndrome character-
ized by brief recurrent episodes of vertigo trig-
gered by changes in head position with respect to
gravity. BPPV is the most common cause of recur-
rent vertigo, with a lifetime prevalence of 2.4%.1
The term BPPV excludes vertigo caused by le-
sions of the CNS. BPPV results from abnormal
stimulation of the cupula within any of the three
semicircular canals (figure e-1 on theNeurology®
Web site at www.neurology.org); most cases of
BPPV affect the posterior canal. The cupular exci-
tatory response is usually related to movement of
otoliths (calcium carbonate crystals) that create a
current of endolymph within the affected semicir-
cular canal. The most common form of BPPV oc-
curswhen otoliths from themacula of the utricle fall
into the lumen of the posterior semicircular canal
responding to the effect of gravity. These ectopic
otoliths, which have been observed intraoperatively,
are referred to as canaliths. The canaliths are dense
and move in the semicircular canal when the head
position is changedwith respect to gravity; the cana-
lith movement ultimately deflects the cupula, lead-
ing to a burst of vertigo and nystagmus. In some
cases, canaliths adhere to the cupula, causing cupu-
lolithiasis, which is a form of BPPV less responsive
to treatment maneuvers.
Typical signs of BPPV are evoked when the
head is positioned so that the plane of the affected
semicircular canal is spatially vertical and thus
aligned with gravity. This produces a paroxysm
of vertigo and nystagmus after a brief latency. Po-
sitioning the head in the opposite direction re-
verses the direction of the nystagmus. These
responses often fatigue upon repeat positioning.
The duration, frequency, and intensity of symptoms
of BPPV vary, and spontaneous recovery occurs fre-
quently. Table e-1 outlines the characteristics of
BPPV by canal type.
Repositioning maneuvers are believed to treat
BPPV by moving the canaliths from the semicir-
cular canal to the vestibule from which they are
absorbed. There are a number of repositioning
maneuvers in use, but they lack standardization.
The figures and Web-based video clips do not in-
clude all variations but represent those maneuvers
and treatments used in the Class I and Class II
studies that are reviewed as well as several others
in common use.
This practice parameter seeks to answer the fol-
lowing questions: 1) What maneuvers effectively
treat posterior canal BPPV? 2)Whichmaneuvers are
effective for anterior and horizontal canal BPPV? 3)
Are postmaneuver restrictions necessary? 4) Is con-
current mastoid vibration important for efficacy of
the maneuvers? 5) What is the efficacy of habitua-
tion exercises, Brandt–Daroff exercises, or patient
self-administered treatmentmaneuvers? 6) Aremed-
ications effective for BPPV? 7) Is surgical occlusion
of the posterior canal or singular neurectomy effec-
tive for BPPV?
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DESCRIPTION OF THE ANALYTIC PROCESS
Otoneurologists with expertise in BPPV and gen-
eral neurologists with methodologic expertise
were invited by the Quality Standards Subcom-
mittee (appendix e-1) to perform this review. Us-
ing the four-tiered classification scheme described
in appendix e-2, author panelists rated all rele-
vant articles between 1966 and June 2006.
Articles included in this analysis met all of these
criteria: 1) BPPV was diagnosed by both symptoms
of positional vertigo lasting less than 60 seconds,
and paroxysmal positional nystagmus in response
to the Dix–Hallpike maneuver (figure 1) or other
appropriate provocative maneuver; 2) for all forms
of BPPV, the nystagmuswas characterized by a brief
latency before the onset of nystagmus or a reduction
of nystagmus with repeat Dix–Hallpike maneuvers
(fatigability); 3) for posterior canal BPPV, a positive
Dix–Hallpike maneuver was defined by the pres-
ence of upbeating and torsional nystagmus with the
top pole of rotation beating toward the affected
(downside) ear; and 4) for horizontal canal BPPV,
the Dix–Hallpike or supine roll maneuver produced
horizontal geotropic (toward the ground) or apo-
geotropic (away from the ground) direction-
changing paroxysmal positional nystagmus.
Geotropic direction-changing positional nystag-
mus refers to paroxysmal right beating nystagmus
when the supine head is turned to the right and
paroxysmal left beating nystagmus with the su-
pine head turned to the left. Conversely, apogeo-
tropic indicates the nystagmus is right beating
with the head turned to the left and left beating
with head turned to the right.
ANALYSIS OF EVIDENCE Question 1: What
maneuvers effectively treat posterior canal BPPV?
Canalith repositioning procedure for BPPV.Of15 ran-
domized controlled trials identified, there were
two Class I studies2,3 and three Class II studies.4-6
The first Class I study of 36 patients2 com-
pared the canalith repositioning procedure (CRP)
(figure 2) with a sham maneuver where the pa-
tient was placed in a supine position with the af-
fected ear down for 5 minutes and then sat up. All
patients were symptomatic for at least 2 months;
the median duration of symptoms was 17 months
(range 2–240 months) in the treatment group and
4 months (range 2–276 months) in the control
group, a difference that approached significance.
At 4 weeks, 61% of the treated group reported
complete symptom resolution, vs 20% of the
sham-treated group (p  0.032). The number
needed to treat (NNT) was 2.44. The NNT is an
epidemiologic measure that indicates the number
of patients that had to have treatment to elimi-
nate symptoms in one patient. The Dix–Hallpike
maneuver was negative in 88.9% of treated pa-
tients vs 26.7% in sham-treated patients (p 
0.001; NNT  1.60), as measured by an observer
blinded to treatment.
The second Class I randomized controlled trial
and crossover study,3 of 66 patients with a diag-
nosis of posterior BPPV based on a positive Dix–
Hallpike maneuver, compared a CRP (figure 2)
with a sham procedure. The sham procedure con-
sisted of a CRP performed on the contralateral,
asymptomatic ear.
After 24 hours, 80% of treated patients were
asymptomatic and had no nystagmus with the
Dix–Hallpike maneuver compared with 10% of
sham patients (p  0.001; NNT  1.43). At this
point, all patients in both the treatment and con-
trol groups with a persistently positive Dix–
Hallpike maneuver underwent a CRP. Ninety-
three percent of patients from the original control
group reported resolution of symptoms 24 hours
after undergoing the CRP. By 1 week, 94% of pa-
tients in the original treatment group and 82% of
patients in the original control group (all of whom
underwent a CRP at 24 hours) were asymptomatic
(p value not stated). At 4 weeks, 85% of patients in
both groups were asymptomatic.
Three studies were rated as Class II because
the method of allocation concealment was not
specified. Allocation concealment is a technique
for preventing researchers from inadvertently in-
fluencing which patients are assigned to the treat-
ment or placebo group; inadequate allocation
concealment may cause selection bias that overes-
timates the treatment effect.7
The first Class II study of 50 patients4 com-
pared a CRP with the same sham maneuver per-
formed by Lynn et al.,2 with blinded outcome
measurements of symptom resolution and absent
Figure 1 Dix–Hallpike maneuver for diagnosis of
right posterior canal benign
paroxysmal positional vertigo
(BPPV)
The patient’s head is turned 45 degrees toward the side to
be tested and then laid back quickly. If BPPV is present, nys-
tagmus ensues usually within seconds.
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nystagmus in response to the Dix–Hallpike ma-
neuver. One to 2 weeks after treatment, 50%
of the treated group reported symptom resolution
vs 19% in the sham group, an absolute difference
of 31% (95% CI 0.06-0.56, p  0.02; NNT 
3.22). Using the absence of nystagmus after the
Dix–Hallpike maneuver as an outcome measure-
ment, an improvement was seen in 65% of
treated patients vs 38% of sham patients, a
27% absolute difference (95% CI 0.02– 0.52,
p  0.046; NNT  3.7).
Another Class II study5 randomized 29 pa-
tients to a CRP and another 29 patients to no
treatment. The diagnosis of posterior BPPV was
based on observing nystagmus after the Dix–
Hallpike maneuver and a “complete neurotologi-
cal examination.” All patients were given a
prescription for cinnarizine to use for vertigo.
Over the next month, all patients were exam-
ined at weekly intervals by a blinded observer.
Patients with a positive Dix–Hallpike maneu-
ver who were assigned to the treatment group
underwent repeat CRP. A questionnaire was
administered to patients with a negative Dix–
Hallpike maneuver.
At 1 week, 41% of treated patients were symp-
tom free, vs 3% of untreated controls (p 0.005;
NNT  2.63). The Dix–Hallpike maneuver was
negative in 75.9% of treated patients vs 48.2% of
untreated controls, an absolute difference of
27.7% (95% CI 0.241–0.489, p  0.03; NNT 
3.68). At 2 weeks, 65% were symptom free in the
treatment group vs 3% of controls (p 0.005). At
3 weeks, 65% were symptom free vs 21% of the
controls (p  0.014). There were no significant
differences at 4 weeks. The control group used
cinnarizine more often (23 doses) than did the
treatment group (5.8 doses, p 0.001).
The third study6 randomized 124 patients to a
CRP, a Semont liberatory maneuver (figure 3),
Brandt–Daroff exercises (figure e-2), habituation
exercises, or a sham maneuver of slow neck rota-
tion and flexion performed with the patient in a
sitting position. The diagnosis for posterior canal
BPPV was based on history and paroxysmal posi-
tional nystagmus in response to the Dix–Hallpike
maneuver (figure 1). The median duration of
symptoms was 4 months (range 10 days to 30
years). The outcome measure was an arbitrary
patient-rated vertigo intensity and frequency scale
of 1 to 10 (10 being the most severe or frequent),
recorded by a blinded observer.
The treatment effect in this study is difficult to
quantify because the results are expressed in the
form of regression curves, rather than as discrete
values. At 90 days after treatment, vertigo fre-
quency was reportedly “significantly reduced” in
both CRP– and Semont maneuver–treated pa-
tients. Both treatment maneuvers were superior
to the sham maneuver (CRP, p  0.021; Semont
maneuver, p  0.010) for vertigo intensity. The
vertigo scores were not significantly different be-
tween the CRP and Semont maneuver. There was
significantly less frequent vertigo in those treated
by either CRP or Semont maneuver compared
with Brandt–Daroff exercises (p 0.033).
The remaining randomized controlled trials
were graded as Class IV because they did not
clearly state whether the outcomes were obtained
in a blinded and independent manner8-15 or be-
cause of important baseline differences between
study and control groups.16
The literature search also yielded four meta-
analyses and one systematic review. All four
Figure 2 Canalith repositioning procedure for right-sided benign paroxysmal
positional vertigo
Steps 1 and 2 are identical to the Dix–Hallpike maneuver. The patient is held in the right head
hanging position (Step 2) for 20 to 30 seconds, and then in Step 3 the head is turned 90
degrees toward the unaffected side. Step 3 is held for 20 to 30 seconds before turning the
head another 90 degrees (Step 4) so the head is nearly in the face-down position. Step 4 is
held for 20 to 30 seconds, and then the patient is brought to the sitting up position. The
movement of the otolith material within the labyrinth is depicted with each step, showing how
otoliths are moved from the semicircular canal to the vestibule. Although it is advisable for
the examiner to guide the patient through these steps, it is the patient’s head position that is
the key to a successful treatment.
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meta-analyses17-20 concluded that CRP and Se-
mont maneuver have significantly greater efficacy
than no treatment in BPPV. All references in-
cluded in these four meta-analyses were reviewed
individually for this practice parameter.
In all these studies, complications of nausea
and vomiting, fainting, or conversion to horizon-
tal canal BPPV occurred in 12% of patients. In a
retrospective study of 85 patients treated with a
CRP,21 6% developed a conversion to either hori-
zontal canal BPPV or anterior canal BPPV.
Semont maneuver for BPPV. One Class II study6
showed that patients treated with Semont maneu-
ver were “significantly” improved compared with
those treated with a sham maneuver. A Class III
study22 randomized 156 patients to Semont ma-
neuver, medical therapy (flunarizine 10 mg/day
for 60 days), or no treatment. At 6-month follow-
up, 94.2% of patients treated with Semont ma-
neuver reported symptom resolution, vs 57.7% of
patients treated with flunarizine and 34.6% of pa-
tients who received no treatment.
A Class IV study23 comparing Semont maneu-
ver and a CRP either with or without post-
treatment instructions found success rates for all
groups ranging from 88% to 96%, with no differ-
ences between groups. Another Class IV study24
compared patients randomized to treatment with
CRP, Semont maneuver, or Brandt–Daroff exer-
cises. Symptom resolution among those treated
with either CRP or Semont maneuver at 1 week
was the same (74% vs 71%; 24% for Brandt–
Daroff exercises). At 3-month follow-up, 93% of
patients treated with CRP were asymptomatic vs
77% of those treated with Semont maneuver (p
0.027); 62% of patients treated with Brandt–
Daroff exercises were asymptomatic at 3 months.
Conclusion. Two Class I studies and three Class
II studies have demonstrated a short-term (1 day
to 4 weeks) resolution of symptoms in patients
treated with the CRP, with NNT ranging from
1.43 to 3.7. The Semont maneuver is possibly
more effective than no treatment (Class III), a
sham treatment (Class II), or Brandt–Daroff exer-
cises (Class IV) as treatment for posterior canal
BPPV. Two Class IV studies comparing CRP with
Semont maneuver have produced conflicting re-
sults; one showed no difference between groups,
and the other showed a lower recurrence rate in
patients undergoing CRP.
Recommendation (appendix e-3). Canalith reposi-
tioning procedure is established as an effective
and safe therapy that should be offered to patients
of all ages with posterior semicircular canal BPPV
(Level A recommendation). The Semont maneu-
ver is possibly effective for BPPV but receives only
a Level C recommendation based on a single
Class II study. Although many experts believe
that the Semont maneuver is as effective as cana-
lith repositioning maneuver, based on currently
published articles the Semont maneuver can only
be classified as “possibly effective.” There is in-
sufficient evidence to establish the relative effi-
cacy of the Semont maneuver to CRP (Level U).
Question 2: Which maneuvers are the most effective
treatments for horizontal canal and anterior canal
BPPV? Horizontal canal BPPV. Horizontal canal
BPPV accounts for 10% to 17% of BPPV,25-29
though some reports have been even higher.30,31
The nystagmus of horizontal canal BPPV is hori-
zontal and changes direction when the head is
turned to the right or left while supine (direction-
changing paroxysmal positional nystagmus). The
direction-changing positional nystagmus may be
either geotropic or apogeotropic.31 The geotropic
form, which is thought to result from free-moving
otoconial debris in the long arm of the semicircular
duct, is generally more responsive to treatment. The
apogeotropic form is likely due to otoconial mate-
rial in the short arm of the canal or attached to the
cupula (cupulolithiasis).24,32 Hence, one seeks to
convert the more treatment-resistant apogeotropic
to the more treatment-responsive geotropic nystag-
mus form of horizontal canal BPPV.32,33
The nystagmus and vertigo of horizontal canal
BPPV may be provoked by the Dix–Hallpike ma-
neuver but are more reliably induced by the su-
pine head roll test or so-called Pagnini–McClure
maneuver (figure 4).34-36 The methods used to de-
Figure 3 Semont maneuver for right-sided benign paroxysmal positional vertigo
While sitting up in Step 1, the patient’s head is turned 45 degrees toward the left side, and
then the patient is rapidly moved to the side-lying position as depicted in Step 2. This position
is held for 30 seconds or so, and then the patient is rapidly taken to the opposite side-lying
position without pausing in the sitting position or changing the head position relative to the
shoulder. This is in contrast to the Brandt–Daroff exercises that entail pausing in the sitting
position and turning the head with body position changes.
2070 Neurology 70 May 27, 2008 (Part 1 of 2)
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maneuvers have been devised.
Variations of the roll maneuver (Lempert ma-
neuver or barbecue roll maneuver) (figure 5) are
the most widely published treatments for hori-
zontal canal BPPV.25,26,29,31,32,34,36,38,e1,e2 Success in
treatment, based on all Class IV studies, is proba-
bly 75%32,e2 but ranges from approximately
50% to nearly 100%. However, the studies used
differing and sometimes unclear endpoints, and
many lacked control groups to allow comparison
between the treatment and the natural rate of res-
olution of this condition.
The Gufoni maneuver is another technique
that has been reported as effective in treating hor-
izontal canal BPPVe3 (figure e-3, A and B). Several
studies, all Class IV, have reported success using
this or a similar maneuver for horizontal canal
BPPV for both the geotropic and apogeotropic
nystagmus forms.32,33,38,e4 Similarly, the Vannuc-
chi–Asprella liberatory maneuver may be effec-
tive, but there is only limited Class IV data
supporting its use.38,e5,e6 Casani et al.32 and Appiani
et al.33 review other techniques used with success in
the treatment of both the geotropic and apogeotro-
pic forms of horizontal canal BPPV.
Another treatment reported as effective30,32,36,e2,e7
is referred to as forced prolonged positioning. With
this method, the patient lies down laterally to the
affected side, and the head is then turned 45 degrees
toward the ground and maintained in that position
for 12 hours before the patient is returned to the
starting position. Some authors advocate this tech-
nique for refractory horizontal canal BPPV.32,e3 Us-
ing this approach, one Class IV study reported
remission rates of 75% to 90%.32
Anterior canal BPPV.Anterior canal BPPV is usu-
ally transitory and most often is the result of “ca-
nal switch” that occurs in the course of treating
other more common forms of BPPV.21
We identified only two studies specifically ad-
dressing the treatment of anterior canal BPPV;
both were Class IV studies.e8,e9 Success rates were
between 92% and 97%, though there were no
controls to determine whether this represents an
improvement over the natural history of this fre-
quently self-resolving form of BPPV.
Conclusion. Based on Class IV studies, variations
of the Lempert supine roll maneuver, the Gufoni
method, or forced prolonged positioning seemmod-
erately effective for horizontal canal BPPV.Twoun-
controlled Class IV studies report high response
rates to maneuvers for anterior canal BPPV.
Recommendation:None (Level U).
Question 3: Are postmaneuver activity restrictions
necessary after canalith repositioning procedure? In
one Class I study2 and one Class II4 study demon-
strating the benefit of CRP, patients wore a cervi-
cal collar for 48 hours and avoided sleeping on the
Figure 4 Supine roll test (Pagnini–McClure maneuver) to detect horizontal canal
benign paroxysmal positional vertigo (BPPV)
The patient may be taken from sitting to straight supine position (1). The head is turned to the
right side (2) with observation of nystagmus and then turned back to face up (1). Then the
head is turned to the left side (3). The side with the most prominent nystagmus is taken to be
the affected horizontal semicircular canal. The direction of nystagmus in each position deter-
mines whether the horizontal canal BPPV is of the geotropic or apogeotropic type.
Figure 5 Lempert roll maneuver for right-sided horizontal canal benign
paroxysmal positional vertigo (BPPV)
When it is determined to be horizontal canal BPPV affecting the right side, the patient is taken
through a series of step-wise 90-degree turns away from the affected side in Steps 1
through 5, holding each position for 10 to 30 seconds. From Step 5, the patient positions his
or her body to the back (6) in preparation for the rapid and simultaneous movement from the
supine face up to the sitting position (7).
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affected side for 1 week. One Class I study3 and
two Class II studies5,6 that demonstrated the ben-
efit of CRP used no post-treatment restrictions or
instructions. These studies were not designed to
determine whether such restrictions affect treat-
ment success; however, there seems to be little dif-
ference in the rate of treatment success whether or
not restrictions were included.
Six Class IV studies comparing CRP with and
without post-treatment activity restriction were
identified.23,e10-e14 Five studies23,e10-e13 showed no
added benefit from post-treatment activity re-
striction or positions. Only one study showed a
minimal benefit in patients with post-activity re-
strictions, as measured by the number of maneu-
vers required to produce a negative Dix–Hallpike
maneuver.e14
Conclusion and recommendation. Five Class IV
studies support the omission of post-treatment
activity restrictions; one study supports the use of
post-treatment restrictions. There is insufficient
evidence to determine the efficacy of post-
maneuver restrictions in patients treated with
CRP (Level U).
Question 4: Is it necessary to include mastoid vibration
with repositioning maneuvers? Mastoid vibration
was included in the original Epley repositioning
maneuver. One Class II study,e15 comparing pa-
tients with posterior canal BPPV treated by “ap-
propriate canalith repositioning maneuvers,”
performed with and without vibration, showed
no difference in immediate symptom resolution
or relapse rate between groups.
A Class III studye16 compared patients treated
by CRP with and without mastoid vibration.
There was no difference in symptom relief be-
tween the groups at 4 to 6 weeks (p 0.68).
Two Class IV studiese17,e18 showed no differ-
ence in the rate of symptom resolution between
patients treated by a CRP with or without mas-
toid vibration. A third Class IV study9 reported
that of patients treated by a CRP with vibration,
92% were “improved,” vs 60% improvement
with CRP alone.
Conclusion and recommendation.OneClass II, one
Class III, and two Class IV studies showed no
added benefit when mastoid vibration was added
to a CRP as treatment for posterior canal BPPV.
Mastoid oscillation is probably of no added bene-
fit to patients treated with CRP for posterior ca-
nal BPPV (Level C recommendation).
Question 5: What is the efficacy of Brandt–Daroff
exercises, habituation exercises, or patient self-
administered treatments for BPPV? A Class II study
that randomized patients to a CRP, a “liberatory
maneuver,” Brandt–Daroff exercises, “habituation
exercises,” or a sham treatment found that patients
treatedwith habituation exercises did no better than
those treated with a sham procedure.6 Patients
treated with Brandt–Daroff exercises did worse
than those treated with CRP or liberatory maneu-
vers but were not compared with sham-treated
patients.
A Class IV study24 compared Brandt–Daroff
exercises, performed three times daily, with the
Semont maneuver or CRP. Patients treated with
maneuvers were pretreated with diazepam and
given postmaneuver activity restrictions; patients
treated with Brandt–Daroff exercises were not.
Compliance with the exercises was not recorded.
At 1-week follow-up, 24% of patients treated
with Brandt–Daroff exercises were symptom free,
vs 74% of those treated with the Semont maneu-
ver or CRP. Given the limitations of the study, its
validity is questionable.
Three Class IV studies investigated the effi-
cacy of patient-administered treatment for
BPPV using various techniques. One study
found 88% improvement of BPPV when treated
with CRP and home CRP compared with 69%
improvement in those only treated with CRP
once.e19 Another study reported improved reso-
lution of nystagmus among patients that self-
administered CRP (64% recovery) vs self-
administered Brandt–Daroff exercises (23%).e20
The third study found that 95% had resolution
of positional nystagmus 1 week after self-
treatment with CRP vs 58% of self-treatment
with a modified Semont maneuver.e21
Conclusion and recommendation.One Class II and
one Class IV study suggest that Brandt–Daroff
exercises or habituation exercises are less effective
than CRP in the treatment of posterior canal
BPPV. Self-administered Brandt–Daroff exercises
or habituation exercises are less effective than
CRP in the treatment of posterior canal BPPV
(Level C). There is insufficient evidence to recom-
mend or refute self-treatment using Semont ma-
neuver or CRP for BPPV (Level U).
Question 6: What is the efficacy of medication treat-
ments for BPPV? One Class III studye22 found no
difference between lorazepam, 1 mg three times
daily; diazepam, 5 mg three times daily; or pla-
cebo over the 4-week study period. Another Class
III study21 found that flunarizine was more effec-
tive than no treatment but less effective than Se-
mont maneuver in eliminating symptoms. There
are no randomized controlled trials of meclizine
2072 Neurology 70 May 27, 2008 (Part 1 of 2)
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or other drugs used for motion sickness in the
treatment of BPPV.
Conclusion and recommendation.A single Class III
study did not demonstrate that lorazepam or di-
azepam hastened resolution of symptoms in
BPPV. A single Class III study demonstrated some
benefit of flunarizine, a drug that is unavailable in
the United States, in BPPV. There is no evidence
to support a recommendation of any medication
in the routine treatment for BPPV (Level U).
Question 7: What are the safety and efficacy of sur-
gical treatments for posterior canal BPPV? All stud-
ies of surgical treatment for refractory BPPV are
Class IV. The most common procedure is fenes-
tration and occlusion of the posterior semicircu-
lar canal. Five studies, e23-e27 with a total of 86
patients undergoing canal occlusion, reported
“complete relief” of BPPV symptoms in 85, as as-
certained by the treating surgeon. Reported com-
plications included a “mild” conductive hearing
loss for 4 weeks or less, “mild” and “transient”
unsteadiness in most patients, and a high fre-
quency sensorineural hearing loss in 6 patients.
In a Class IV study of singular neurectomy
as a treatment for intractable BPPV,e28 96.8%
were reported to have “complete relief”; severe
sensorineural hearing loss occurred in 3.7% of
patients.
Conclusion and recommendation. Six unblinded,
retrospective Class IV studies report relief from
symptoms of BPPV in nearly every patient under-
going posterior semicircular canal occlusion or
singular neurectomy. Because the studies are
Class IV, they do not provide sufficient evidence
to recommend or refute posterior semicircular ca-
nal occlusion or singular neurectomy as treatment
for BPPV (Level U).
RECOMMENDATIONS FOR FUTURE RE-
SEARCH Class I studies are needed to clarify the
best treatments for horizontal canal BPPV. Future
studies on these topics should adhere to the
Consolidated Standards of Reporting Trials
(CONSORT) criteria using validated, clinically
relevant outcomes.
PROGNOSIS AND RECURRENCE RATE The re-
lapse rate and second recurrence rate of BPPV are
not fully established. Short-term relapse rates range
from 7% to nearly 23% within a year of treatment,
but long-term recurrences may approach 50%, de-
pending on the age of the patient. e29-e32
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